Journal of Laboratory Medicine and Quality Assurance

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-7261   pISSN 2384-2458

Table. 11.

Table. 11.

2017 external quality assessment result of antituberculous drug susceptibility test

Drugs1st trial2nd trial3rd trial



MTS1701MTS1702MTS1703MTS1704MTS1705MTS1706MTS1707MTS1708MTS1709MTS1710MTS1711MTS1712MTS1713MTS1714MTS 1715















SRSRSRSRSRSRSRSRSRSRSRSRSRSRSR
Amikacin333332222244444
Capreomycin3333322122244444
Cycloserine22222111111133333
Ethambutol31444433333235555
Isoniazid444443333366666
Kanamycin333332222244444
Levofloxacin333332222244444
Moxifloxacin333312112222444314
Ofloxacin333332222244444
PAS333332222244444
Prothionamide1111111111221122
Pyrazinamide3333121122221344431
Rifabutin3333322222444413
Rifampin444443333366666
Streptomycin4444433333555541

Abbreviations: R, resistant; S, susceptible; PAS, para-aminosalicylic acid.

J Lab Med Qual Assur 2019;41:82-104 https://doi.org/10.15263/jlmqa.2019.41.2.82
© 2019 J Lab Med Qual Assur